His primary areas of investigation include Pulmonary hypertension, Internal medicine, Respiratory disease, Anesthesia and Endocrinology. His research in Pulmonary hypertension intersects with topics in Iloprost, Sildenafil, Vascular resistance, Lung and Pulmonary artery. His Lung research includes themes of Hypoxia and Pharmacology.
His studies deal with areas such as Gastroenterology, Biochemistry, Surgery and Cardiology as well as Internal medicine. His biological study spans a wide range of topics, including Oxidative stress and Bronchoalveolar lavage. His work carried out in the field of Endocrinology brings together such families of science as BMPR2, Gene expression and Obstructive sleep apnea.
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Cardiology, Lung and Pharmacology. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Surgery. His Pulmonary hypertension research integrates issues from Anesthesia, Hypoxia, Pathology, Vascular resistance and Pulmonary artery.
His Anesthesia study combines topics in areas such as Respiratory disease and Iloprost. The various areas that Friedrich Grimminger examines in his Cardiology study include Sildenafil and Blood pressure. His Pharmacology research incorporates themes from Biochemistry, Immunology and Vasodilation.
Friedrich Grimminger mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Cancer research and Riociguat. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Surgery. The Surgery study combines topics in areas such as Sildenafil and Treprostinil.
Friedrich Grimminger interconnects Ventricular pressure, Pathology, COPD, Lung and Pulmonary artery in the investigation of issues within Pulmonary hypertension. His work deals with themes such as Anesthesia, Blood pressure, MEDLINE and Hazard ratio, which intersect with Cardiology. His Riociguat research includes elements of Gastroenterology, Tolerability and Clinical endpoint.
Internal medicine, Pulmonary hypertension, Cardiology, Cancer research and Pathology are his primary areas of study. The various areas that Friedrich Grimminger examines in his Internal medicine study include Endocrinology and Surgery. Friedrich Grimminger usually deals with Surgery and limits it to topics linked to Vascular resistance and Cardiac index.
His work deals with themes such as Inflammation, COPD, Lung, Disease and Hemodynamics, which intersect with Pulmonary hypertension. His Cancer research research is multidisciplinary, relying on both Hypoxia, Cancer cell, Immunology, Metastasis and Idiopathic pulmonary fibrosis. Friedrich Grimminger combines subjects such as Muscle hypertrophy and Immune system with his study of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sildenafil citrate therapy for pulmonary arterial hypertension.
Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst.
The New England Journal of Medicine (2005)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig.
The New England Journal of Medicine (2013)
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Hossein-Ardeschir Ghofrani;Andrea M D'Armini;Friedrich Grimminger;Marius M Hoeper.
The New England Journal of Medicine (2013)
Reversal of experimental pulmonary hypertension by PDGF inhibition.
Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti.
Journal of Clinical Investigation (2005)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly.
The Lancet (2002)
Real-time quantitative RT–PCR after laser-assisted cell picking
Ludger Fink;Werner Seeger;Leander Ermert;Jörg Hänze.
Nature Medicine (1998)
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.
Richard Schulz;Siamak Mahmoudi;Katja Hattar;Ulf Sibelius.
American Journal of Respiratory and Critical Care Medicine (2000)
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski.
Annals of Internal Medicine (2002)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly;Hossein A. Ghofrani;Martin R. Wilkins;Friedrich Grimminger.
Nature Reviews Cardiology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: